Browse through our recent news and keep up to date with the latest on what’s been happening at Neuroclin Glasgow.
What is Parkinson’s Disease?
What Causes Parkinson’s Disease? The exact cause of Parkinson’s disease remains unknown, but research shows that it involves the gradual loss of dopamine-producing neurons in a specific part of the brain called the ‘substantia nigra’ (Latin for ‘black substance’) located on the lower side of the midbrain. Dopamine is a crucial chemical messenger, referred to … Continued
My Journey at NeuroClin and Why I’m Running for Parkinson’s Research
By Monica Harley Expanding Our Research: From Alzheimer’s to Parkinson’s and Beyond For many patients, the idea of attending a clinical trial appointment may feel daunting, but at NeuroClin, we’re committed to making the experience as smooth and supportive as possible. Our dedicated team, combined with our world-class facilities, all helps make research a much … Continued
Understanding Alzheimer’s Disease
Alzheimer’s Symptoms Alzheimer’s disease may be subdivided into early onset, late-onset , mixed and unspecified. The symptoms are varied for different people . Some of the more common symptoms and warning signs of the disease may include: Alzheimer’s Disease Causes Alzheimer’s disease is thought to be caused by the abnormal build-up of proteins in and around … Continued
NeuroClin appoints new Chief Executive
Plans also unveiled for a new site in North West England during the third quarter. NeuroClin has appointed Fiona Wood as its new chief executive. The Glasgow-headquartered clinical research facility has also confirmed that an agreement has been reached to open a new site in north west England this autumn.Wood joins the business from Clyde … Continued
NeuroClin and Dementia Action Week 2024: Together Towards Better Diagnosis
This week Neuroclin marks the commencement of Dementia Action Week, running from 13th to 19th May 2024. Spearheaded by the Alzheimer’s Society, this initiative seeks to mobilise the UK in significantly enhancing the diagnosis rates of dementia. It’s a stark reality that 1 in 3 people living with dementia are undiagnosed, underlining the critical importance … Continued
How Dementia Affects Women Differently
With women being 65 per cent of the people affected by dementia, we must make sure that any new therapy works for them as well as men.
A Year of Progress: Reflecting on 2023 at NeuroClin
In the ever-evolving world of medical research, 2023 has proven to be a transformative one for our clinic. From embracing new studies to engaging with the community in novel ways, we’ve experienced remarkable growth and innovation. Join us as we take a journey through the highlights of the past year, celebrating the achievements that have … Continued
New Depression Study: Seeking Volunteers Aged 18-74
As part of our continued diversification into new neuro clinical areas of research. We are pleased to announce that Glasgow Memory Clinic is now initiating a groundbreaking study on depression, and we are actively seeking volunteers to participate. If you are between the ages of 18 and 74, have a diagnosis of depression and are … Continued
Scoring Hope and Memories: Tackling Alzheimer’s in World Alzheimer’s Month
1 in 3 people born today will go on to develop Alzheimer’s Football can create many of life’s greatest moments, shared with friends and family. But unfortunately, many people living with dementia will forget these memories. In Scotland, over 90,000 people have dementia. That could almost fill Hampden stadium twice or Glasgow City FC‘s home … Continued
NeuroClin partners with Glasgow City FC
NeuroClin has taken a giant leap toward making a meaningful impact on the world of clinical research by partnering with Glasgow City Football Club for the 2023/24 season. This ground-breaking collaboration sees NeuroClin proudly stepping into the role of the club’s new sleeve and matchday programme sponsor, marking a significant stride in their shared pursuit of advancing treatments for Memory Impairment, Alzheimer’s disease, Dementia and other neurological conditions.